TCL Archive Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups July 8, 2011
TCL Archive In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind January 23, 1976
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
